WASHINGTON (Reuters) – The Federal Trade Commission will seek to stop Illumina Inc’s $7.1 billion proposed acquisition of cancer detection test maker Grail Inc, the agency said in a statement on Tuesday. The agency said the deal would slow innovation for tests that are designed to detect multiple kinds of cancer. Illumina, a life sciences […]